Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $16.7600 -0.0600 % -0.3600 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: -0.36% […]
Read MoreCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTIC $5.7600 0.2000 % 3.6000 Cti […]
Read MoreSIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA $9.7000 0.3100 % 3.3000 Siga Technologies Inc Sector : Medical Industry : Medical […]
Read MoreMarket conditions are Bullish in a Bear Market as of 2022-11-08. This means traders and investors should consider trading with a Neutral or Bullish bias by buying stocks and setting tight stops. The rank of the Bear Market is -19.97 which indicates the current market conditions are Extreme, Risk of a reversal is high. The […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. CPRX $14.0600 […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $13.9000 0.5000 % 3.7300 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 3.73% […]
Read MoreCorcept Therapeutics Incorporated (CORT) Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia. Relmada Therapeutics, Inc. (RLMD) Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on […]
Read MoreRelmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017). RLMD $35.0400 1.8100 % 5.4500 Relmada Therapeutics Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long […]
Read MoreTheravance Biopharma, Inc. (TBPH) Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Fusion Pharmaceuticals Inc. (FUSN) Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $15.2300 0.3600 % 2.4200 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 2.42% […]
Read MoreAltimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. ALT $21.0900 -0.9900 % -4.4800 Altimmune Inc […]
Read MoreBioVie Inc. (BIVI) BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis. Infinity Pharmaceuticals, Inc. (INFI) Infinity Pharmaceuticals, Inc., a biopharmaceutical […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $13.9500 0.1100 % 0.7900 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 0.79% […]
Read MoreBuy Price: $7.35 or better Sell Price: TradersPro Sell Signal Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The stocks founds […]
Read More